Structure-Based Design and Computational Validation of Novel 1,3,4-Thiadiazole-Peptide Conjugates As Selective Cyclin-Dependent Kinase-2 (CDK2) Inhibitors for Lung Cancer Therapy. Pjmcr 2026, 5 (2), 1174-1180. https://doi.org/10.66021/pakmcr903.